HCA:NYE-HCA Holdings Inc.

EQUITY | Health Care Providers | New York Stock Exchange

Last Closing

USD 129.06

Change

+0.89 (+0.69)%

Market Cap

USD 26.31B

Volume

1.13M

Analyst Target

USD 153.08
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-06-18 )

Largest Industry Peers for Health Care Providers

ETFs Containing HCA

YALL God Bless America ETF 4.94 % 0.00 %

-0.20 (0.00%)

USD 0.07B
ZWHC:CA BMO Covered Call Health C.. 4.72 % 0.00 %

N/A

CAD 0.01B
RUFF ETF Opportunities Trust -.. 4.36 % 0.00 %

-0.26 (0.00%)

USD 0.06B
MHG:AU Magellan Global Equities 4.24 % 0.00 %

-0.04 (0.00%)

USD 0.11B
MGE:AU 4.11 % 0.00 %

N/A

N/A
FXH First Trust Health Care A.. 0.00 % 0.63 %

+0.37 (+0.00%)

USD 1.33B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.67 (+0.00%)

USD 0.82B
NASH 0.00 % 0.49 %

N/A

N/A
PKW Invesco BuyBack Achievers.. 0.00 % 0.62 %

+0.73 (+0.00%)

USD 1.09B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.06 (+0.00%)

CAD 0.08B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
RYH Invesco S&P 500® Equal W.. 0.00 % 0.40 %

N/A

USD 1.01B
WBIL WBI BullBear Quality 3000.. 0.00 % 1.07 %

-0.04 (0.00%)

USD 0.04B
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

+1.00 (+0.00%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Health Care Providers) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.70% 74% C 26% F
Dividend Return 0.64% 83% B 23% F
Total Return 4.35% 74% C 24% F
Trailing 12 Months  
Capital Gain 21.81% 100% F 92% A
Dividend Return 1.42% 83% B 23% F
Total Return 23.23% 100% F 91% A-
Trailing 5 Years  
Capital Gain 131.25% 81% B- 95% A
Dividend Return 3.94% 43% F 13% F
Total Return 135.19% 81% B- 94% A
Average Annual (5 Year Horizon)  
Capital Gain 18.32% 84% B 91% A-
Dividend Return 18.69% 84% B 90% A-
Total Return 0.36% 38% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 24.02% 53% F 26% F
Risk Adjusted Return 77.80% 84% B 77% C+
Market Capitalization 26.31B 100% F 96% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Care Providers) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.50 47% 52%
Price/Book Ratio -7.89 89% 98%
Price / Cash Flow Ratio 1.73 47% 64%
Price/Free Cash Flow Ratio 13.98 26% 41%
Management Effectiveness  
Return on Equity -66.47% 16% 3%
Return on Invested Capital 25.24% 95% 89%
Return on Assets 9.95% 95% 88%
Debt to Equity Ratio -585.25% 84% 98%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Negative Book Value

The company has negative book value.